Analyst Ratings for Arcus Biosciences (RCUS)
RCUS Rating Summary
RCUS Price Target Summary
- Highest: $70.00 (BTIG)
- Lowest: $23.00 (BofA Securities)
- Average: $41.57
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$41.57 (+182.2%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
Avg. $ Target:
$41.57 (+182.2%)
* Over Last 12-Mos
Rating Score: 8.5 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/16/2024 | Truist Securities | Asthika Goonewardene | New Coverage | Buy (N/A) |
50.00 (N/A) |
16.58 (14.73) |
-11.16% | Details |
| 11/18/2022 | BofA Securities » Updated 9/5/2023 |
Jason Zemansky | New Coverage | Neutral (N/A) |
23.00 (21.00) |
28.74 (14.73) |
-48.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
